Feb 17, 2026 08:45AM
Jan 27, 2026 09:02AM
Jan 27, 2026 09:00AM
Dec 29, 2025 05:11AM
Dec 26, 2025 06:36PM
Dec 24, 2025 10:40AM
Dec 24, 2025 09:00AM FDA approves Omeros' YARTEMLEA for stem cell transplant complication
Dec 24, 2025 09:00AM
Dec 1, 2025 08:30AM
Dec 1, 2025 08:30AM
Nov 13, 2025 04:11PM
Nov 11, 2025 08:30AM
Oct 16, 2025 08:33AM
Oct 16, 2025 08:30AM Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group
Oct 15, 2025 08:30AM
Sep 2, 2025 08:45AM
Sep 2, 2025 08:45AM
Aug 14, 2025 04:02PM
Aug 11, 2025 04:02PM
Jul 25, 2025 08:00AM
Jul 25, 2025 08:00AM Omeros Corporation Announces Pricing of $22 Million Registered Direct Offering
Jun 27, 2025 08:31AM
Jun 27, 2025 08:30AM
Jun 24, 2025 08:30AM
May 15, 2025 04:05PM
May 12, 2025 05:05PM
May 12, 2025 08:41AM
May 12, 2025 08:41AM  Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026
May 6, 2025 09:16AM
May 6, 2025 09:16AM
Apr 10, 2025 09:10AM
Apr 10, 2025 09:10AM
Apr 8, 2025 09:00AM
Mar 31, 2025 04:02PM
Mar 26, 2025 09:15AM Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025
Mar 21, 2025 09:15AM
Mar 21, 2025 09:15AM
Mar 13, 2025 09:00AM
Feb 20, 2025 09:11AM
Feb 20, 2025 09:10AM
Feb 14, 2025 09:00AM
Feb 10, 2025 09:00AM Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
Jan 16, 2025 09:16AM
Jan 16, 2025 09:15AM
Dec 23, 2024 07:07AM
Dec 19, 2024 09:15AM
Dec 19, 2024 09:15AM
Dec 10, 2024 08:45AM
Dec 10, 2024 08:45AM Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting
Dec 2, 2024 08:45AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All